Overall, our data suggest that CAD204520 inhibits NOTCH1 PEST mutations in both cell lines and in primary CLL samples, retaining the advantageous anti-tumor effect on mutated WT cells. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.